Midterm 2 Drugs to Know Flashcards
Optivar (azelastine)
topical mast cell stabilizer + antihistamine
antihistamine: binds to and stabilizes inactive state of H1 receptors
mast cell stabilizer: prevents mast cell degranulation; prevents further release of histamine and newly formed inflammatory mediators
Elestat (epinastine)
topical mast cell stabilizer + antihistamine
antihistamine: binds to and stabilizes inactive state of H1 receptors
mast cell stabilizer: prevents mast cell degranulation; prevents further release of histamine and newly formed inflammatory mediators
Bepreve (bepotastine)
topical mast cell stabilizer + antihistamine
antihistamine: binds to and stabilizes inactive state of H1 receptors
mast cell stabilizer: prevents mast cell degranulation; prevents further release of histamine and newly formed inflammatory mediators
Patanol (olopatadine 0.1%)
topical mast cell stabilizer + antihistamine
antihistamine: binds to and stabilizes inactive state of H1 receptors
mast cell stabilizer: prevents mast cell degranulation; prevents further release of histamine and newly formed inflammatory mediators
Pataday (olopatadine 0.2%)
topical mast cell stabilizer + antihistamine
antihistamine: binds to and stabilizes inactive state of H1 receptors
mast cell stabilizer: prevents mast cell degranulation; prevents further release of histamine and newly formed inflammatory mediators
Pazeo (olopatadine 0.7%)
topical mast cell stabilizer + antihistamine
antihistamine: binds to and stabilizes inactive state of H1 receptors
mast cell stabilizer: prevents mast cell degranulation; prevents further release of histamine and newly formed inflammatory mediators
Lastacaft (alcaftadine)
topical mast cell stabilizer + antihistamine
antihistamine: binds to and stabilizes inactive state of H1 receptors
mast cell stabilizer: prevents mast cell degranulation; prevents further release of histamine and newly formed inflammatory mediators
Alaway, Zaditor (ketotifen fumarate)
topical mast cell stabilizer + antihistamine
antihistamine: binds to and stabilizes inactive state of H1 receptors
mast cell stabilizer: prevents mast cell degranulation; prevents further release of histamine and newly formed inflammatory mediators
Alocril (nedocromil)
topical mast cell stabilizer
prevents mast cell degranulation; prevents further release of histamine and newly formed inflammatory mediators
Alomide (lodoxamide)
topical mast cell stabilizer
prevents mast cell degranulation; prevents further release of histamine and newly formed inflammatory mediators
Crolom (cromolyn sodium)
topical mast cell stabilizer
prevents mast cell degranulation; prevents further release of histamine and newly formed inflammatory mediators
Acular LS (ketorolac 0.4%)
topical NSAID
blocks the cyclooxygenase pathway; prevents inflammatory mediators from forming; increases the sensitivity threshold of nerve endings; helps alleviate itching
Acuvail (ketorolac 0.45%)
topical NSAID
blocks the cyclooxygenase pathway; prevents inflammatory mediators from forming; increases the sensitivity threshold of nerve endings; helps alleviate itching
Acular (ketorolac 0.5%)
topical NSAID
blocks the cyclooxygenase pathway; prevents inflammatory mediators from forming; increases the sensitivity threshold of nerve endings; helps alleviate itching
Nevanac (nepafenac 0.3%)
topical NSAID
blocks the cyclooxygenase pathway; prevents inflammatory mediators from forming; increases the sensitivity threshold of nerve endings; helps alleviate itching
Ilevro (nepafenac 0.3%)
topical NSAID
blocks the cyclooxygenase pathway; prevents inflammatory mediators from forming; increases the sensitivity threshold of nerve endings; helps alleviate itching
Prolensa (bromfenac 0.07%)
topical NSAID
blocks the cyclooxygenase pathway; prevents inflammatory mediators from forming; increases the sensitivity threshold of nerve endings; helps alleviate itching
Bromsite (bromfenac 0.075%)
topical NSAID
blocks the cyclooxygenase pathway; prevents inflammatory mediators from forming; increases the sensitivity threshold of nerve endings; helps alleviate itching
Voltaren (diclofenac 0.1%)
topical NSAID
blocks the cyclooxygenase pathway; prevents inflammatory mediators from forming; increases the sensitivity threshold of nerve endings; helps alleviate itching
Alrex (loteprednol 0.2%)
topical corticosteroid
inhibits phospholipase A2 and stabilizes mast cells; prevents release of antihistamine; inhibits AA pathway which inhibits formation of inflammatory mediators
Lotemax (loteprednol 0.5%)
topical corticosteroid
inhibits phospholipase A2 and stabilizes mast cells; prevents release of antihistamine; inhibits AA pathway which inhibits formation of inflammatory mediators
FML (fluorometholone alcohol 0.1%)
topical corticosteroid
inhibits phospholipase A2 and stabilizes mast cells; prevents release of antihistamine; inhibits AA pathway which inhibits formation of inflammatory mediators
Flarex (fluorometholone acetate 0.1%)
topical corticosteroid
inhibits phospholipase A2 and stabilizes mast cells; prevents release of antihistamine; inhibits AA pathway which inhibits formation of inflammatory mediators
Pred Forte (prednisolone acetate 1%)
topical corticosteroid
inhibits phospholipase A2 and stabilizes mast cells; prevents release of antihistamine; inhibits AA pathway which inhibits formation of inflammatory mediators
Veramyst
nasal corticosteroid
inhibits phospholipase A2 and stabilizes mast cells; prevents release of antihistamine; inhibits AA pathway which inhibits formation of inflammatory mediators
Nasacort
nasal corticosteroid
inhibits phospholipase A2 and stabilizes mast cells; prevents release of antihistamine; inhibits AA pathway which inhibits formation of inflammatory mediators
Flonase
nasal corticosteroid
inhibits phospholipase A2 and stabilizes mast cells; prevents release of antihistamine; inhibits AA pathway which inhibits formation of inflammatory mediators
Medrol Dosepak
oral corticosteroid
inhibits phospholipase A2 and stabilizes mast cells; prevents release of antihistamine; inhibits AA pathway which inhibits formation of inflammatory mediators
phenylephrine 0.12%
topical decongestant
adrenergic agonist; act on alpha adrenergic receptors in conj blood vessels, causing vasoconstriction; provides only symptomatic relief, no effect on immune response to allergen
naphazoline
topical decongestant
adrenergic agonist; act on alpha adrenergic receptors in conj blood vessels, causing vasoconstriction; provides only symptomatic relief, no effect on immune response to allergen
tetrahydrozoline (visine)
topical decongestant
adrenergic agonist; act on alpha adrenergic receptors in conj blood vessels, causing vasoconstriction; provides only symptomatic relief, no effect on immune response to allergen
oxymetazoline
topical decongestant
adrenergic agonist; act on alpha adrenergic receptors in conj blood vessels, causing vasoconstriction; provides only symptomatic relief, no effect on immune response to allergen
Naphcon-A (pheniramine maleate + naphazoline)
topical decongestant + antihistamine
topical decongestant: adrenergic agonist; act on alpha adrenergic receptors in conj blood vessels, causing vasoconstriction; provides only symptomatic relief, no effect on immune response to allergen
antihistamine: binds to and stabilizes inactive state of H1 receptors
Cisine-A (pheniramine maleate + naphazoline)
topical decongestant + antihistamine
topical decongestant: adrenergic agonist; act on alpha adrenergic receptors in conj blood vessels, causing vasoconstriction; provides only symptomatic relief, no effect on immune response to allergen
antihistamine: binds to and stabilizes inactive state of H1 receptors
Opcon-A (pheniramine maleate + naphazoline)
topical decongestant + antihistamine
topical decongestant: adrenergic agonist; act on alpha adrenergic receptors in conj blood vessels, causing vasoconstriction; provides only symptomatic relief, no effect on immune response to allergen
antihistamine: binds to and stabilizes inactive state of H1 receptors
Benadryl (diphenhydramine)
1st generation oral antihistamine
binds to and stabilizes inactive state of H1 receptors
Phenergan (promethazine)
1st generation oral antihistamine
binds to and stabilizes inactive state of H1 receptors
Tavist (clemastine)
1st generation oral antihistamine
binds to and stabilizes inactive state of H1 receptors
Chlor-trimeton (chlorpheniramine)
1st generation oral antihistamine
binds to and stabilizes inactive state of H1 receptors
Allegra (fexofenadine)
2nd generation oral antihistamine
binds to and stabilizes inactive state of H1 receptors
Claritin (loratadine)
2nd generation oral antihistamine
binds to and stabilizes inactive state of H1 receptors
Clarinex (desloratadine)
2nd generation oral antihistamine
binds to and stabilizes inactive state of H1 receptors
Zyrtec (cetirizine)
2nd generation oral antihistamine
binds to and stabilizes inactive state of H1 receptors